CPHI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Home Market News Agility will be the focus for Pharmaceutical and Medical Device Markets in 2016, says AMPLEXOR Life Sciences
News
10 Dec 2015

Agility will be the focus for Pharmaceutical and Medical Device Markets in 2016, says AMPLEXOR Life Sciences

The newly branded technology and services group warns that current market pressures demand a more holistic approach to global data handling.

Until the life sciences industry treats content management holistically, its ability to seize new market opportunities may be limited. So says Mark Evenepoel, group CEO of AMPLEXOR — the newly branded 360-degree content management corporation which brings together four technology and services powerhouses: euroscript, INFOTEHNA, ForeignExchange Translations, and Amplexor.

The combined group, rebranded as AMPLEXOR, will incorporate the AMPLEXOR Life Sciences brand as of today, and specializes in helping life sciences organizations accelerate their speed to market and enter new countries quickly. Its solutions and services expedite the creation and delivery of consistent, compliant and high-quality global content — both physical and digital — across all of a company’s target markets.

“Without a consistent, holistic approach to all forms of content, life sciences companies will never be truly agile,” Evenepoel warns. “The industry knows that, and I believe 2016 will be a turning point.”

His comments chime with research published by Gens & Associates (Next Generation Content Management “Pulse Survey”) in April. This suggests that life sciences organizations which manage their content at a holistic, pan-enterprise level derive greater value from their investments. All companies surveyed expect to move towards an enterprise-wide approach to content management governance within the next 2-5 years, as they strive to create a global authoritative source of content and information sharing.

  • “Silos hamper speed to market. They risk inaccuracy, and compromise the ability to deliver correct content quickly to where it’s needed,” Evenepoel notes. “Content management in the life sciences industry must transcend individual initiatives such as IDMP [Identification of Medical Products] compliance. Companies need a reliable way to manage not just what’s submitted to regulators, but also what goes out on the packaging, and on their web site, and what’s distributed across digital and social media — in every region and every country.”

    Employing 1,600 people in 24 countries across four continents, AMPLEXOR Life Sciences has a 30+ year history of serving the biggest names in the pharmaceutical, medical device and biotechnology markets. It combines euroscript, a leading life sciences content management implementation specialist; INFOTEHNA, with its powerful content management platform and leading suite of life sciences solutions; ForeignExchange Translations, which provides expert professional medical translation, and Amplexor, a digital experience platform for managing content across web, mobile and social channels.

    With its comprehensive technology solutions and professional services, spanning all forms of physical and digital content, AMPLEXOR Life Sciences is a leading, visionary one-stop-shop partner for life sciences companies. Its services include technology consultancy, implementation and management services; technical writing & linguistic services, and marketing asset creation and management.

    “We’re very excited about the year ahead,” says Evenepoel, who before the rebranding was CEO of euroscript. “Pharma, medical device manufacturers and biotech firms face some significant challenges in 2016 as they align themselves with the latest regulatory reporting requirements while simultaneously racing competitors to bring out new products and enter new markets.

    “There is so much going on for the sector right now. What we’re offering them is a lasting solution to one of the core challenges: managing all of the content and keeping it compliant and consistent wherever it appears ─ and ready to go as soon as it’s needed.”

    • Related tags
    Market

    Related News